SYMBIOTA™

Precision Microbiome Technology for Next-Generation Functional Ingredients

Microbiome science is evolving beyond probiotics.

SYMBIOTA™ is Microbio’s proprietary microbiome platform developed to create highly functional postbiotic ingredients through precision microbial design and symbiotic fermentation technology.

Built upon more than two decades of pharmaceutical and microbiome research, SYMBIOTA™ transforms complex microbial interactions into stable, scalable, and commercially ready solutions for global health and wellness applications.

A Different Approach to Microbiome Innovation

Many microbiome products focus on adding beneficial bacteria. SYMBIOTA™ takes a different path. Through carefully designed microbial ecosystems and proprietary symbiotic fermentation technology, SYMBIOTA™ generates bioactive postbiotic ingredients that help support microbiome balance and targeted physiological functions. This approach enables greater formulation flexibility, improved stability, and broader application opportunities compared with conventional live probiotic solutions.

Symbiota precision symbitic fermentation

What Makes Symbiota™ Different?

A Precision Microbiome Platform Designed Beyond Conventional Postbiotics

SYMBIOTA™ combines precision microbial selection with proprietary multi-strain symbiotic fermentation to create differentiated postbiotic ingredients.
By leveraging microbial interactions within a controlled fermentation ecosystem, SYMBIOTA™ generates diverse bioactive compounds designed to support targeted health and wellness applications.

Key Technology Advantages

Multi-strain synergy
Complete metabolite profile
Nano-sized metabolites
Stable & flexible formulation
Over 20 international patents
More than 1,600 microbial solution libraries

Global Quality and Regulatory Readiness

SYMBIOTA™ is supported by internationally recognized quality systems and global commercialization strategies.

Key advantages include:

• U.S. GRAS-supported market strategy

• International patent protection

• Scalable manufacturing capabilities

• Powder and liquid ingredient formats

• Global application opportunities

Explore the Symbiota™ Ingredient

Metabolic
Glucose Control

Gut
Immune Health

Liver Detox
Gut-Liver Axis

Endocrine
Puberty Timing

Skin Microbiome
Cosmetics

Finished Product Opportunities

Commercial Success Stories

From Platform Innovation to Market-Proven Products

From pharmaceutical innovation to consumer wellness solutions, SYMBIOTA™ has demonstrated successful commercialization across multiple product categories. These market-proven applications highlight the versatility and scalability of Microbio’s microbiome platform, transforming scientific innovation into commercially successful products.

Pharmaceutical Applications

Chemo young (MS-20)

Developed through over a decade of research and development, Chemo Young is an oral therapy approved in Taiwan as an adjuvant treatment for cancer patients. Built upon the scientific foundation of SYMBIOTA™, MS-20 represents a significant milestone in the translation of microbiome research into pharmaceutical innovation.

Digestive Health & Wellness

“Tien Chun Bao” Prime Enzyme

A consumer health product formulated with SYMBIOTA™ technology to support digestive wellness and microbiome balance. Prime Enzyme demonstrates how microbiome-derived ingredients can be incorporated into everyday nutritional solutions designed for a broad range of consumers.

Microsoy

Combining traditional fermentation expertise with modern microbiome science, Microsoy has become a recognized health food product supporting digestive and overall wellness. Its success highlights the adaptability of SYMBIOTA™ technology across functional food applications.

Young

Developed using advanced fermentation technologies, Young is designed to support digestive wellness and overall health maintenance. The product reflects the potential of SYMBIOTA™ technology in creating innovative consumer health solutions based on microbiome science.